BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Delcath Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:21 pm Sale | 2024-09-30 | 13G | Delcath Systems, Inc. DCTH | BIOTECHNOLOGY VALUE FUND L P | 1,041,667 3.600% | -1,296,759 (-55.45%) | Filing |
| 2024-02-14 10:08 am Purchase | 2023-12-31 | 13G | Delcath Systems, Inc. DCTH | BIOTECHNOLOGY VALUE FUND L P | 2,338,426 9.990% | 776,912 (+49.75%) | Filing |
| 2023-06-22 4:47 pm Purchase | 2023-06-12 | 13G | Delcath Systems, Inc. DCTH | BIOTECHNOLOGY VALUE FUND L P | 1,561,514 9.990% | 1,561,514 (New Position) | Filing |